Newly Discovered Protein Can Rejuvenate Aging Brain Cells

Key Takeaways:

• Aging neural stem cells may be silenced, not lost. In models of telomere dysfunction, stem cells remained present but entered a non-dividing, epigenetically repressed state
• DMTF1 functions as a molecular control switch. Lower levels were associated with tighter chromatin structure and suppression of genes required for cell proliferation.
• Restoring DMTF1 reactivated stem cell division in experimental systems. The findings suggest some age-related regenerative decline may be reversible at the transcriptional level — though this has not been demonstrated in humans

One of the hallmarks of brain aging is reduced neurogenesis—particularly in the hippocampus, the region involved in learning and memory. Neural stem cells don’t completely disappear with age. Instead, many enter a dysfunctional, non-dividing state.

A new study published in Science Advances identifies a key regulator behind this shutdown: DMTF1, a transcription factor that helps control whether stem cells can divide.

What actually goes wrong with age

In this study, researchers examined neural stem cells with telomere dysfunction — a form of cellular aging caused by damage to chromosome ends. In these aged cells:

• DMTF1 levels were significantly reduced

• Proliferation genes remained silenced

• Chromatin stayed tightly packed and inaccessible

• Stem cells failed to renew

Importantly, the cells weren’t dead. They were arrested.

When researchers restored DMTF1 expression, proliferation capacity was rescued in these telomere-dysfunctional neural stem cells.

How DMTF1 works

DMTF1 doesn’t build neurons directly. It regulates access to the genome.

It activates pathways involving chromatin remodeling complexes (including the SWI/SNF–E2F axis), reopening growth-related gene programs that had been epigenetically suppressed. In other words, aging in this context appeared to involve transcriptional silencing rather than irreversible loss.

Why this matters for longevity

This work supports a broader model of aging biology: some cells may remain present but become epigenetically locked in a non-functional state.

If that lock can be safely reversed, it raises the possibility of restoring tissue function without replacing cells outright.

That said, this is early mechanistic research conducted in experimental models of telomere dysfunction. It does not demonstrate reversal of cognitive aging in humans. And any strategy that enhances stem cell proliferation must carefully consider tumor risk.

Still, the implication is significant: aging may not always erase regenerative capacity. Rather, it may suppress it.

Understanding the molecular “off switches” like DMTF1 is a step toward learning whether they can be turned back on safely.

References: 

Yajing Liang, Oleg V. Grinchuk, Nadia Omega Cipta, Yingying Zeng, You Heng Chuah, Jeehyun Yoon, Zi Jian Khong, Hui Ying Chow, Winanto Ng, Chin Tong Ong, Shuo-Chien Ling, Shi-Yan Ng, Yuin-Han Loh, Derrick Sek Tong Ong. DMTF1 up-regulation rescues proliferation defect of telomere dysfunctional neural stem cells via the SWI/SNF-E2F axis. Science Advances, 2026; 12 (1) DOI: 10.1126/sciadv.ady5905